PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $763,625 | -29.2% | 73,923 | -10.2% | 0.00% | – |
| Q2 2023 | $1,079,320 | -59.7% | 82,328 | -65.7% | 0.00% | – |
| Q1 2023 | $2,680,472 | +201.7% | 239,756 | +127.5% | 0.00% | – |
| Q4 2022 | $888,412 | +39.0% | 105,387 | +174.8% | 0.00% | – |
| Q3 2022 | $639,000 | -56.9% | 38,356 | -61.9% | 0.00% | – |
| Q2 2022 | $1,482,000 | -85.3% | 100,669 | -75.2% | 0.00% | -100.0% |
| Q1 2022 | $10,076,000 | +1156.4% | 406,128 | +1721.2% | 0.00% | – |
| Q3 2021 | $802,000 | +244.2% | 22,300 | +337.3% | 0.00% | – |
| Q1 2021 | $233,000 | – | 5,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $10,278,050 | 5.54% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $621,907 | 2.98% |
| PURA VIDA INVESTMENTS, LLC | 726,298 | $7,502,658 | 1.42% |
| CFM WEALTH PARTNERS LLC | 264,039 | $2,727,523 | 0.71% |
| BRAIDWELL LP | 988,559 | $10,211,814 | 0.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,017,958 | $10,515,506 | 0.23% |
| Rock Springs Capital Management LP | 652,400 | $6,739,292 | 0.18% |
| Point72 Asset Management, L.P. | 2,929,903 | $30,265,898 | 0.09% |
| ALGERT GLOBAL LLC | 117,327 | $1,212 | 0.06% |
| Campbell & CO Investment Adviser LLC | 45,380 | $468,775 | 0.06% |